These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6764243)

  • 1. [Congenital pachyonychia treated by oral retinoid].
    Rondón Lugo AJ
    Med Cutan Ibero Lat Am; 1982; 10(6):395-8. PubMed ID: 6764243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pachyonychia congenita. Three familial cases. Effects of the treatment by aromatic retinoid (RO 10.9359) (author's transl)].
    Dupré A; Christol B; Bonafé JL; Touron P
    Ann Dermatol Venereol; 1981; 108(2):145-9. PubMed ID: 7247217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: retinoid dermatitis].
    Rüst O; Tufli T
    Schweiz Med Wochenschr; 1979 Dec; 109(48):1921-5. PubMed ID: 161414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE; Wishart J; Hodge JL
    N Z Med J; 1981 Aug; 94(689):99-100. PubMed ID: 6944653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral treatment of lamellar ichthyosis (non-bullous congenital ichthyosiform erythroderma) with an aromatic retinoid (author's transl)].
    Frenk E
    Dermatologica; 1981; 162(2):91-103. PubMed ID: 7018943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)].
    Sönnichsen N; Harnack K; Barth J; Heilmann S; Jäger K; Metz D; Schiller F
    Z Hautkr; 1983 Sep; 58(17):1257-67. PubMed ID: 6636927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe disorders of keratinization: effects of treatment with Tigason (etretinate).
    Marks R; Finlay AY; Holt PJ
    Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically.
    Polano MK; van der Rhee HJ; van der Schroeff JG
    Acta Derm Venereol; 1982; 62(4):361-4. PubMed ID: 6183880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)].
    Pehamberger H; Esca SA; Holubar K
    Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined oral retinoid and PUVA therapy in the treatment of psoriasis and psoriatic arthropathy (author's transl)].
    Thivolet J; Robart S; Vignon E
    Ann Dermatol Venereol; 1981; 108(2):131-7. PubMed ID: 6972721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigason (etretinate) treatment in psoriatic arthritis.
    Ciompi ML; Bazzichi L; Marotta G; Pasero G
    Int J Tissue React; 1988; 10(1):25-7. PubMed ID: 3397251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S; Lidén S
    Acta Derm Venereol; 1983; 63(1):89-91. PubMed ID: 6191505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic treatment of oral lichen planus with an aromatic retinoid (Ro 10-9359)].
    Maidhof R
    Z Hautkr; 1979 Oct; 54(19):873-16. PubMed ID: 392969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359).
    El-Ramly M; Zachariae H
    Acta Derm Venereol; 1983; 63(5):452-6. PubMed ID: 6197852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatoses.
    Viglioglia PA
    Br J Dermatol; 1980 Nov; 103(5):483-7. PubMed ID: 7437314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids].
    Fontan B; Bonafé JL; Moatti JP
    Ann Dermatol Venereol; 1983; 110(1):23-31. PubMed ID: 6859752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone complications from chronic etretinate intoxication in children].
    Cointin M; Sommelet-Olive D; Cuny JF; Bretagne MC
    Ann Pediatr (Paris); 1990 Sep; 37(7):458-60. PubMed ID: 2256641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease.
    Burge SM; Wilkinson JD; Miller AJ; Ryan TJ
    Br J Dermatol; 1981 Jun; 104(6):675-9. PubMed ID: 7248178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pityriasis rubra pilaris with an oral aromatic retinoid (RO 10--9359).
    Lauharanta J; Lassus A
    Acta Derm Venereol; 1980; 60(5):461-2. PubMed ID: 6162329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.